CEFEPIME FOR INJECTION USP
HIKMA CANADA LIMITED
Quick answers
Is there a shortage of CEFEPIME FOR INJECTION USP in Canada?
No. There is no current shortage of CEFEPIME FOR INJECTION USP 2G reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
DIN
02499096
Strength
2G
Dosage Form
Powder For Solution
Route
Intravenous
Active Ingredient
CEFEPIME (CEFEPIME HYDROCHLORIDE)
See all CEFEPIME (CEFEPIME HYDROCHLORIDE) products →Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from HIKMA CANADA LIMITED
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
9MG · DIN 02304341
200MG · DIN 02459906
0.4MG · DIN 02432188
0.6MG · DIN 02432196
100MG · DIN 02507668
2MG · DIN 02457075
0.05MG · DIN 02457059
0.2% · DIN 02515377
500MG · DIN 02437104
10G · DIN 02437120
1G · DIN 02437112
750MG · DIN 02422298